44 related articles for article (PubMed ID: 17005798)
1. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
Kuipers S; Brüggemann RJ; de Sévaux RG; Heesakkers JP; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2011 Jul; 55(7):3564-6. PubMed ID: 21502625
[TBL] [Abstract][Full Text] [Related]
2. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O
Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole prophylaxis in hematologic cancer.
Kontoyiannis DP; Lewis RE
N Engl J Med; 2007 May; 356(21):2214-5; author reply 2215-8. PubMed ID: 17526090
[No Abstract] [Full Text] [Related]
4. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Seidler MJ; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2008 Nov; 52(11):4130-6. PubMed ID: 18710910
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole and Voriconazole: The Complexity of Dose Adjustments.
Ito H; Ogawa R
Clin Infect Dis; 2022 Aug; 75(3):552. PubMed ID: 35092680
[No Abstract] [Full Text] [Related]
6. Medical treatment of brain aspergilloma followed by MRI: A case report.
Alahmari AF
Radiol Case Rep; 2019 Jan; 14(1):103-111. PubMed ID: 30386448
[TBL] [Abstract][Full Text] [Related]
7. Intracranial aspergilloma in an immunocompetent geriatric patient: A diagnostic dilemma.
Sharma G; Kumar A; Singh A
Geriatr Gerontol Int; 2024 Apr; 24(4):440-441. PubMed ID: 38391120
[No Abstract] [Full Text] [Related]
8. Regulation of Sterol Biosynthesis in the Human Fungal Pathogen
Dhingra S; Cramer RA
Front Microbiol; 2017; 8():92. PubMed ID: 28203225
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Gregson L; Goodwin J; Johnson A; McEntee L; Moore CB; Richardson M; Hope WW; Howard SJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5778-80. PubMed ID: 24041890
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Mavridou E; Brüggemann RJ; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2010 Feb; 54(2):860-5. PubMed ID: 19917751
[TBL] [Abstract][Full Text] [Related]
11. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Pfaller MA; Diekema DJ; Ghannoum MA; Rex JH; Alexander BD; Andes D; Brown SD; Chaturvedi V; Espinel-Ingroff A; Fowler CL; Johnson EM; Knapp CC; Motyl MR; Ostrosky-Zeichner L; Sheehan DJ; Walsh TJ;
J Clin Microbiol; 2009 Oct; 47(10):3142-6. PubMed ID: 19692559
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli.
Etienne KA; Kano R; Balajee SA
J Clin Microbiol; 2009 Apr; 47(4):1096-100. PubMed ID: 19244469
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
14. Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?
Rodriguez-Tudela JL; Alcazar-Fuoli L; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
Antimicrob Agents Chemother; 2007 Dec; 51(12):4502-4. PubMed ID: 17938188
[TBL] [Abstract][Full Text] [Related]
15. Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Dannaoui E; Garcia-Hermoso D; Naccache JM; Meneau I; Sanglard D; Bouges-Michel C; Valeyre D; Lortholary O
J Med Microbiol; 2006 Oct; 55(Pt 10):1457-1459. PubMed ID: 17005798
[TBL] [Abstract][Full Text] [Related]
16. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
17. Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Beernaert LA; Pasmans F; Van Waeyenberghe L; Dorrestein GM; Verstappen F; Vercammen F; Haesebrouck F; Martel A
Antimicrob Agents Chemother; 2009 May; 53(5):2199-201. PubMed ID: 19258265
[TBL] [Abstract][Full Text] [Related]
18. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
Verweij PE; Te Dorsthorst DT; Rijs AJ; De Vries-Hospers HG; Meis JF
J Clin Microbiol; 2002 Jul; 40(7):2648-50. PubMed ID: 12089298
[TBL] [Abstract][Full Text] [Related]
19. [Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Verweij PE; van de Sande-Bruisma N; Kema GH; Melchers WJ
Ned Tijdschr Geneeskd; 2012; 156(25):A4458. PubMed ID: 22748367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
